Check with local hiring managers or HR representatives for country-specific regulations.Explore MoreEMPLOYEE'S HEALTH In today's fast-paced and demanding world, the importance of employee well-being cannot be overstated. We are proud of our Global Employee Health Program BeHealthy, a comprehensive...
Services Kennzahlenvergleich Downloads Vergleich zum Vorjahr Feedback Weiterführende Links Healthcare Healthcare Forschung und Entwicklung Diese Seite teilen: E-Mail Facebook Twitter LinkedIn Unternehmen Karriere Forschung Nachhaltigkeit Presse Kontakt Events Standorte Life Science ...
Milli-Q® HR 7000高通量中央水纯化系统 了解我们的其他品牌 将安全的新疗法推向市场,需要具有专业知识的适当合作伙伴。 这就是Merck提供BioReliance® 的原因 — 从新药开发直到审批入市的每个环节,它都是您的合作伙伴,向您提供我们范围广泛的产品系列,涵盖生物制药特征化、安全性测试、工艺开发、临床和商...
Check with local hiring managers or HR representatives for country-specific regulations. Explore More
At the final analysis of the study, there was also an improvement in overall survival (OS) for patients treated with KEYTRUDA in combination with chemotherapy compared to chemotherapy alone; however, these OS results did not meet statistical significance per the pre-specified statistical plan (HR=...
HOMER.center Howspace HPCBOX HPE Virtual Support Agent HROne ハブポイント バイ サグラ HubSite 365 Huddo Boards Teams の Humantelligence HunchBuzz ハイブリッドの正常 ハイブリッド 合理化機能 HybRooms 誇大 広告 ハイパーリンク Hyperproof EU Hyperproof Gov Ideamap Ideanote アイデ...
Their first points of contact are their supervisors, HR or compliance teams. Alternatively, employees can also make anonymous calls to our compliance hotline. In 2022, 20 alleged cases of discrimination were reported via the compliance hotline and other channels, seven incidents were confirmed. ...
282845 - HR Business Partner - California 282932 - Operations Coordinator 283050 - Associate Director, U.S. BAVENCIO Marketing 283159 - Ürün Tanıtım Uzmanı (Onkoloji) - İstanbul/Avrupa Bölgesi 281464 - QA Supervisor - Irvine 283069 - Director Market Access, Government Af...
Im Januar haben wir zudem das neue Milliflex-Oasis®-System eingeführt, das noch zuverlässigere Ergebnisse, eine höhere Produktivität und eine bessere Nachverfolgung gewährleistet. Das System optimiert pharmazeutische Bioburden- und Wassertests unter anderem mit 96 neuen ...
The approval is based on data from the Phase 3 NRG-GY018 trial, also known as KEYNOTE-868, in which KEYTRUDA plus carboplatin and paclitaxel followed by KEYTRUDA alone reduced the risk of disease progression or death by 40% (HR...